Literature DB >> 30932978

68Ga-PSMA Uptake in Fibrous Dysplasia.

Maria Lucia Reale1, Consuelo Buttigliero1, Marcello Tucci1, Roberto Giardino2, Carlo Poti3.   

Abstract

Prostate cancer is one of the most common malignancies. Imaging tools play an important role throughout the entire process of the disease. The scenario, however, is going to change. Thanks to a higher sensitivity and specificity, the use of the prostate-specific membrane antigen (PSMA) PET is of increasing importance, particularly at the time of diagnosis and in case of biochemical recurrence. Nevertheless, previous reports have described false-positive findings, as tracer-avid physiological findings or benign processes, potential pitfalls for interpretation of Ga-PSMA PET/CT. Here we report a case of PSMA uptake in a histologically proven fibrous dysplasia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30932978     DOI: 10.1097/RLU.0000000000002546

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  [68 Ga]Ga-PSMA-11 Small Bowel Uptake in Crohn's Disease: Revisiting the "Non-specificity" of PSMA Ligands.

Authors:  Kunal Ramesh Chandekar; Sindhu Tanigassalam; Anwin Joseph Kavanal; Harmandeep Singh; Anish Bhattacharya; Ravimohan Suryanarayan Mavuduru
Journal:  Nucl Med Mol Imaging       Date:  2022-01-29

2.  68Ga-PSMA-11 uptake in tracheal mucus plug - a potential pitfall.

Authors:  Kunal Ramesh Chandekar; Apurva Sood; Rajender Kumar; Harmandeep Singh; Shrawan Kumar Singh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-31

Review 3.  PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Authors:  Ahmed Ebada Salem; Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

4.  Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?

Authors:  Charles Marcus; Yoram Baum; Olayinka A Abiodun-Ojo; Ashesh B Jani; David M Schuster
Journal:  Clin Nucl Med       Date:  2021-05-01       Impact factor: 10.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.